Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

DLL4 antibody

This Mouse Monoclonal antibody specifically detects DLL4 in FACS. It exhibits reactivity toward Human and has been mentioned in 3+ publications.
Catalog No. ABIN2749211

Quick Overview for DLL4 antibody (ABIN2749211)

Target

See all DLL4 Antibodies
DLL4 (delta-Like 4 (DLL4))

Reactivity

  • 57
  • 40
  • 19
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Host

  • 64
  • 16
  • 9
  • 3
  • 1
Mouse

Clonality

  • 65
  • 27
  • 1
Monoclonal

Conjugate

  • 58
  • 9
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This DLL4 antibody is un-conjugated

Application

  • 49
  • 34
  • 22
  • 14
  • 13
  • 13
  • 11
  • 10
  • 9
  • 5
  • 5
  • 4
  • 4
  • 3
  • 2
  • 1
  • 1
Flow Cytometry (FACS)

Clone

MHD4-46
  • Purpose

    Anti-DLL4 Purified

    Specificity

    The mouse monoclonal antibody MHD4-46 recognizes the extracellular domain of DLL4 (Delta-like ligand 4), a type I transmembrane protein which plays an important role in vascular development.

    Cross-Reactivity (Details)

    Human

    Purification

    Purified by protein-A affinity chromatography.

    Purity

    > 95 % (by SDS-PAGE)

    Immunogen

    recombinant soluble human DLL4

    Isotype

    IgG1 kappa
  • Application Notes

    Flow cytometry: Recommended dilution: 1-4 μg/mL

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Store at 2-8°C. Do not freeze.
  • Sekine, Koyanagi, Koyama, Hozumi, Chiba, Yagita: "Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes." in: Arthritis research & therapy, Vol. 14, Issue 2, pp. R45, (2012) (PubMed).

    Oishi, Sunamura, Egawa, Motoi, Unno, Furukawa, Habib, Yagita: "Blockade of delta-like ligand 4 signaling inhibits both growth and angiogenesis of pancreatic cancer." in: Pancreas, Vol. 39, Issue 6, pp. 897-903, (2010) (PubMed).

    Yamanda, Ebihara, Asada, Okazaki, Niu, Ebihara, Koyanagi, Yamaguchi, Yagita, Arai: "Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockade." in: Blood, Vol. 113, Issue 15, pp. 3631-9, (2009) (PubMed).

  • Target

    DLL4 (delta-Like 4 (DLL4))

    Alternative Name

    DLL4

    Background

    Delta like canonical Notch ligand 4,DLL4 (Delta-like 4) is one of five ligands of Notch receptors. It interacts with Notch1 and Notch4. DLL4 is up-regulated at sites of physiologic and pathologic angiogenesis, whereas its expression is low in most adult normal tissues. It is also highly expressed in human clear-cell renal carcinomas, bladder cancers, and breast cancers. Blocking the DLL4-Notch interaction seems to be a promissing therapeutic approach.,Delta like ligand 4, AOS6, canonical Notch ligand 4

    Gene ID

    54567

    UniProt

    Q9NR61

    Pathways

    Notch Signaling
You are here:
Chat with us!